Benzinga's Small Cap Movers for Monday December 3, 2012
Shares of Tandy Brands Accessories (NASDAQ: TBAC), the Dallas, TX designer and marketer of branded men's, women's and children's accessories, rose 3% Monday on 12 times average volume.
Tandy Brands announced Monday that it has entered into a multi-year license agreement with Samsonite IP Holding S.A.R.L to design, manufacture, market, distribute and sell products in its gift category in the United States and Canada under the brands Samsonite and American Tourister.
Under the terms of the agreement, Tandy Brands will have rights in a number of product categories, including, but not limited to, cooler bags, storage containers, tools, handheld lighting and other home and personal accessories. The Company expects to drive incremental distribution in a number of wholesale channels, including national retail and department stores, clubs and mass merchants.
Tandy Brands closed at $1.38 on Monday.
Shares of Neuralstem (NYSE: CUR), the Rockville, MD stem cell company, rose 19% Monday on more than twice average volume.
An article in Crain's Detroit Business mentioned a patient being treated with stem cells obtained from Neuralstem in 2011. The patient was daignosed with ALS in 2009 and had responded favorably to treatment.
Neuralstem closed at $1.49 on Monday.
Cambium Learning Group
Shares of Cambium Learning Group (NASDAQ: ABCD), the Dallas, TX provider of research-based education solutions for students in Pre-K through 12th grade, rose 17% Monday on 4.5 times average volume.
ExploreLearning, a division of Cambium Learning announced that students have now solved over one billion addition, subtraction, multiplication and division facts using Reflex. ExploreLearning Reflex is a research-based program that uses the allure of challenging and exciting games to get students engaged and working at peak performance in developing instant recall of math facts.
Cambium Learning Group closed at $1.09 on Monday.
The information in this article is taken from public sources, press releases, and websites that cannot always be verified. Please note that investing in microcap stocks is highly speculative. The companies mentioned here are for information purposes only. Benzinga makes no claim as to the suitability of these stocks as an investment. Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.